インテュイティブ・サージカルに関するコメント

Intuitive Surgical's high P/E ratio is due to its promising earnings outlook, with investors showing confidence in the company's future prosperity. The perceived low risk of earnings deterioration is bolstering the share price.

Despite lower returns in the short term, the reinvestment for growth and higher sales are encouraging signs for Intuitive Surgical. If these growth trends continue, the stock could be a good investment going forward.

The market participants seem to hold the company in higher regard given its growth track record. The sentiment around the company has been positive lately, which could indicate some real business momentum.

Citi and Truist Securities analysts maintain Buy ratings on Intuitive Surgical, praising its new generation of robotic surgery. They expect the company to remain the innovation leader in the rapidly growing robotic surgery category.

Which sector are you bullish on in 2024?
Artificial Intelligence in Healthcare
Artificial intelligence (AI) hit nearly every sector of the US economy in 2023, with some showing disparate impact over others. However, one long-term area in which AI will have an outsized impact is within healthcare trends. AI’s impact in healthcare sectors should compound at 37% annually, hitting $187.95 billion by 2023 compared to just $15.1 billion las...

Many investors find the high P/E ratio of Intuitive Surgical, Inc. acceptable due to its bright future growth prospects. These positive conditions, along with the company's impressive earnings outlook, support its share price.

Gary Guthart, Intuitive's CEO, radiates positivity on Kolli's appointment, considers her insights especially in digital capabilities and customer experiences indispensable as the firm strives to break minimally invasive care boundaries.